Tango Therapeutics
Price & Volume
Stats
See more52W Range | $1.03-$12.01 |
Market Cap | $642.7M |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $40.9M |
Revenue Growth (YoY) | -16.7% |
Gross Profit (12 Mos) | -$101.3M |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 9 days ago
Tango Therapeutics' SWOT analysis: biotech stock's potential in precision cancer therapies
Yahoo Finance • 19 days ago
Tango Therapeutics doses first patient in cancer drug combo trial
Yahoo Finance • 19 days ago
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer
Yahoo Finance • last month
Tango Therapeutics' SWOT analysis: stock poised for growth amid clinical trials
About
CEO | Dr. Barbara L. Weber M.D. |
Address | 201 Brookline Avenue, Boston, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 155 |
